Company Name: Trevena, Inc.
Trevena, Inc. is a clinical stage biopharmaceutical company. The company is engaged in the development and discovery of GPCR biased ligands. The company’s product candidates include treatments for:
- Moderate-to-severe acute pain (intravenous)
- Moderate-to-severe acute and chronic pain (oral)
- Acute episodic migraine and other central nervous system disorders
- Acute heart failure
Ticker Symbol: TRVN (NASDAQ)
Company Website: www.trevenainc.com
Social Media: Trevena LinkedIn
Headquarters: King of Prussia, PA